Research and experimental development on natural sciences and engineering
ZELLUNA IMMUNOTHERAPY AS
Revenue 2024
NOK 53,000
Operating profit
NOK −109.6m
Equity
NOK 36.0m
Incorporated
2016
Employees
9
Share capital
NOK 2.0m
Organisation
Employees
9
Established
2016-01-25
Industry code
72.100
Legal form
AS
Group structure
Eier · 100.0%
ZELLUNA ASA
Company
ZELLUNA IMMUNOTHERAPY AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Utvikle legemidler mot kreft.
Business address
Ullernchausséen 64, 0379 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.